Results 231 to 240 of about 77,045 (328)

Target Trial Emulations of GLP‐1 and Dual GLP‐1/GIP Agonists to Reduce Major Adverse Liver Outcomes in Type 2 Diabetes

open access: yesLiver International, Volume 45, Issue 10, October 2025.
ABSTRACT Background Clinical trials suggest GLP‐1 receptor agonists (RAs) and dual glucagon‐like peptide‐1 (GLP‐1)/glucose‐dependent insulinotropic polypeptide (GIP) RAs improve metabolic dysfunction associated with steatohepatitis (MASH) in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). We aimed to compare the estimate
Alex E. Henney   +5 more
wiley   +1 more source

Natural history of gastric varices

open access: bronze, 1993
WD Chey, Grace H. Elta
openalex   +1 more source

Direct percutaneous embolization of ileal conduit stomal varices with gelatin sponge particles and ethanolamine oleate iopamidol mixture. [PDF]

open access: yesRadiol Case Rep
Yukimoto H   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy